Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients

Critical Care Medicine

Volumn 31, Issue 10, 2003, Pages 2450-2455

  Kramer, Ludwig ^a   Bauer, Edith ^c   Joukhadar, Christian ^a   Strobl, Wolfram ^b   Gendo, Alexandra ^a   Madl, Christian ^a   Gangl, Alfred ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE FOR MICROELECTRONICS   (Austria)

^c NONE

Author keywords

Alkalosis; Cirrhosis; Citrate; Ionized calcium; Regional anticoagulation

Indexed keywords

BICARBONATE; CALCIUM CHLORIDE; CITRATE SODIUM;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; BLOOD PH; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG CLEARANCE; DRUG METABOLISM; FEMALE; HEPATORENAL SYNDROME; HUMAN; INTENSIVE CARE; ITALY; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

APACHE; AREA UNDER CURVE; CASE-CONTROL STUDIES; CITRATES; FEMALE; HALF-LIFE; HUMANS; LIVER CIRRHOSIS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0142025049     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000084871.76568.E6     Document Type: Article

References (26)

1. Flanigan MJ, VonBrecht J, Freeman RM, et al: Reducing the hemorrhagic complications of hemodialysis: A controlled comparison of low dose heparin and citrate anticoagulation. Am J Kidney Dis 1987; 9:147-153
2. Mehta RL, McDonald BR, Aguilar MM, et al: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990; 38:976-981
3. Palsson R, Niles JL: Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999; 55:1991-1997
4. Mehta RL, McDonald BR, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis. An update after 12 months. Contrib Nephrol 1991; 93:210-214
5. Hofbauer R, Moser D, Frass M, et al: Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int 1999; 56:1578-1583
6. Apsner R, Buchmayer H, Lang T, et al: Simplified citrate anticoagulation for high-flux hemodialysis. Am J Kidney Dis 2001; 38:979-987
7. Böhler J, Schollmeyer P, Dressel B, et al: Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: Dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol 1996; 7:234-241
8. Kramer L, Gendo A, Madl C, et al: A controlled study of sorbent suspension dialysis in chronic liver disease and hepatic encephalopathy. Int J Artif Organs 2001; 24:434-442
9. Apsner R, Hörl WH, Sunder-Plassmann G: Dalteparin-induced alopecia in hemodialysis patients: Reversal by regional citrate anticoagulation. Blood 2001; 97:2914-2915
10. Wexler IB, Pincus JB, Natelson S, et al: Fate of citrate in erythroblastic infants treated with exchange transfusion. J Clin Invest 1949; 28:474-481
11. Apsner R, Schwarzenhofer M, Derfler K, et al: Impairment of citrate metabolism in acute hepatic failure. Wien Klin Wochenschr 1997; 109:123-127
12. Meier-Kriesche HU, Finkel KW, Gitomer JJ, et al: Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am J Kidney Dis 1999; 33:E8
13. Diaz J, Acosta F, Parrilla P, et al: Citrate intoxication and blood concentration of ionized calcium in liver transplantation. Transplant Proc 1994; 26:3669-3670
14. Marquez J, Martin D, Virji MA, et al: Cardiovascular depression secondary to ionic hypocalcemia during hepatic transplantation in humans. Anesthesiology 1986; 65:457-461
15. Moriniére P, DeCagny B, El Esper N, et al: Antithrombotic management of the blood circuit in intermittent renal replacement therapy. In: Critical Care Nephrology. Ronco C, Bellomo R (Eds). Amsterdam, Kluwer Academic, 1998, pp 1427-1439
16. Moellering H, Gruber W: Determination of citrate with citrate lyase. Anal Biochem 1966; 17:369-376
17. Marangella M, Vitale C, Manganaro M, et al: Renal handling of citrate in chronic renal insufficiency. Nephron 1991; 57:439-443
18. Hsu CY, Palsson R, Niles JL: Continuous hemofiltration. N Engl J Med 1997; 337:713-714
19. Wilkinson AH, Ash SR, Nissenson AR: Hemodiabsorption in treatment of hepatic failure. J Transpl Coord 1998; 1:43-50
20. Bunker JP, Bendixen HH, Murphy AJ: Hemodynamic effects of intravenously administered sodium citrate. N Engl J Med 1962; 266:372-377
21. Ladenson JH, Miller WB, Sherman LA: Relationship of physical symptoms, ECG, free calcium, and other blood chemistries in reinfusion with citrated blood. Transfusion 1978; 18:670-679
22. Aufeuvre JP, Mortin-Hertel F, Cohen-Solal M, et al: Clinical tolerance and hazards of plasma exchanges: A study of 6200 plasma exchanges in 1033 patients. In: Plasmapheresis in Immunology and Oncology. Beyer JH, Borberg H, Fucha C, et al (Eds). Basel, Switzerland, Karger, 1992, pp 65-77
23. Denlinger JK, Nahrwold ML, Gibbs PS, et al: Hypocalcaemia during rapid blood transfusion in anaesthetized man. Br J Anaesth 1976; 48:995-1000
24. Meier-Kriesche HU, Gitomer JJ, Finkel KW, et al: Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001; 29:748-752
25. Apsner R, Druml W: More on anticoagulation for continuous hemofiltration. N Engl J Med 1998; 338:131-132
26. Hamm LL: Renal handling of citrate. Kidney Int 1990; 38:728-735